Australia-based radiopharmaceutical leader Telix Pharmaceuticals has entered into a definitive agreement to acquire Germany’s ITM Isotope Technologies Munich in a…
Read More
Regeneron Pharmaceuticals and Telix Pharmaceuticals Forge Strategic Alliance to Advance Precision Oncology Through Radiopharmaceutical Innovation
Regeneron Pharmaceuticals and Telix Pharmaceuticals have announced a significant partnership aimed at accelerating the development and commercialization of novel radiopharmaceutical…
Read More
